Results 151 to 160 of about 11,256 (207)

When Genomic Scars Outlive Genomic Vulnerability: Dynamic DNA Damage Repair in Cancer Evolution and Therapeutic Resistance. [PDF]

Genes (Basel)
Ottaiano A, Sabbatino F, Carratù AC, Cascella M, Barone A, Perri F, Belli A, Columbro A, Izzo F, Valeriani M, Correra M, Nasti G, Savarese G.   +12 more
europepmc   +1 more source

Tumor cell intrinsic dsRNA innate immune response triggered by PARP inhibitor is compromised in BRCA1-deficient breast cancer by repressing IRF3. [PDF]

Protein Cell
Zhang C, Zhou JB, Lei JH, Ang IL, Miao K, Xu X, Poon TCW, Cheung E, Deng CX.   +8 more
europepmc   +1 more source

Expanding Synthetic Lethality in DNA Damage Response-Defective Cancers Through Stress Phenotype-Guided Kinase Targeting. [PDF]

Int J Mol Sci
Masi M, Varignani G, Cavalli A, Girotto S.   +3 more
europepmc   +1 more source

HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications. [PDF]

Clin Cancer Res
Banda K, Davies HR, Kumar Y, Memari Y, Degasperi A, Radke M, Rodriguez I, Gooley TA, Katz R, Menghi F, Harding T, Lin K, Liu ET, Nik-Zainal S, Swisher EM.   +14 more
europepmc   +1 more source

CD73 inhibition overcomes adaptive immune resistance to PARP inhibition in models of prostate cancer. [PDF]

J Clin Invest
Xie P, Ma R, Zhang M, Fan J, Tang H, Song L, Wan Y, Kuzel TM, Fang D, Cui W, Wu JD, Abdulkadir SA, Zhang Y, Patnaik A, Zhang B.   +14 more
europepmc   +1 more source

RAUF PARPI SHAXSIYATI VA DUNYOQARASHIGA BIR NAZAR

, 2022
openaire   +2 more sources

FANCA-dependent FEN1 recruitment suppresses transcription-replication conflicts and PARPi sensitivity. [PDF]

Mol Cell
Wang Q, Ellington SW, Guerra P, Gharibpoor F, Simpson DA, Cho MG, Beltran A, Gupta GP.   +7 more
europepmc   +1 more source

Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors. [PDF]

NAR Cancer
Buckley-Benbow L, Ozgencil M, Tardocchi A, Agnarelli A, Bellelli R.   +4 more
europepmc   +1 more source

Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data. [PDF]

Oncol Res
Gasperoni L, Del Bono L, Farolfi A, Messori A, Damuzzo V.   +4 more
europepmc   +1 more source

Autophagy impairs the sensitivity of Ewing sarcoma cells to PARP inhibitors. [PDF]

Cancer Chemother Pharmacol
Clausen J, Kocher D, Schadwinkel HM, Becker S, Milde T, Beck JF, Sonnemann J.   +6 more
europepmc   +1 more source